Show simple item record

dc.contributor.authorRey, Amanda
dc.contributor.authorJürgens Mestre, Ignasi
dc.contributor.authorMaseras, Xavier
dc.contributor.authorDyrda, Agnieszka
dc.contributor.authorPera, Patricia
dc.contributor.authorMorilla Grasa, Antonio
dc.date.accessioned2021-03-24T13:31:20Z
dc.date.available2021-03-24T13:31:20Z
dc.date.issued2018
dc.identifier.citationRey, Amanda; Jürgens Mestre, Ignasi; Maseras, Xavier [et al.]. Visual outcome and complications of cataract extraction after pars plana vitrectomy. Clinical Ophthalmology, 2018, 12, p. 989-994. Disponible en: <https://www.dovepress.com/visual-outcome-and-complications-of-cataract-extraction-after-pars-pla-peer-reviewed-article-OPTH#>. Fecha de acceso: 24 mar. 2020. DOI: 10.2147/OPTH.S161223ca
dc.identifier.issn1177-5483ca
dc.identifier.urihttp://hdl.handle.net/20.500.12328/2435
dc.description.abstractPurpose: To evaluate the visual outcomes and complications of phacoemulsification in previously vitrectomized eyes. Patients and methods: A retrospective analysis of 87 consecutive vitrectomized eyes (87 patients) which had undergone phacoemulsification with intraocular lens implantation between 2013 and 2016. Results: The mean interval from pars plana vitrectomy (PPV) to cataract surgery (CS) was 18.8 months. Mean age at CS was 61.5 years. Intraoperative complications included anterior rhexis tear (1 eye) and hyphema (1 eye). Postoperative complications included macular edema (17.2%, mean 42 days), posterior capsule opacification (13.8%, mean 14 months), ocular hypertension (11.5%), and anterior uveitis (1.1%). Preoperative mean best-corrected visual acuity improved from 20/50 to 20/25. Ninety-one percent of the eyes gained 2 or more lines, and 95% achieved visual acuity ≥20/40 after CS. Preoperative mean spherical equivalent improved from -4.35 to -0.17. Eyes with clear lens prior to the PPV had later CS (clear lens 27.1 vs no clear lens 9.7 months; p=0.016). Patients >55 years with clear lens at PPV (n=21) had earlier CS than younger ones with clear lens (n=24) (11.8 vs 40.5 months; p=0.033). Mean follow-up was 14.5 months. Conclusion: Phacoemulsification is a safe procedure in vitrectomized eyes, with substantial gains in vision in most cases. Patients of advanced age and eyes without clear lens prior to the PPV had earlier CS.en
dc.format.extent6ca
dc.language.isoengca
dc.publisherDove Pressca
dc.relation.ispartofClinical Ophthalmologyca
dc.relation.ispartofseries12;
dc.rightsThis work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.ca
dc.rights.urihttps://creativecommons.org/licenses/by-nc/3.0/
dc.subject.otherCataractes -- Cirurgiaca
dc.subject.otherLents intraocularsca
dc.subject.otherRetina -- Cirurgiaca
dc.subject.otherOftalmologiaca
dc.subject.otherCataratas (Oftalmología) -- Cirugíaes
dc.subject.otherLentes intraoculareses
dc.subject.otherRetina -- Cirugíaes
dc.subject.otherOftalmologíaes
dc.subject.otherCataract -- Surgeryen
dc.subject.otherIntraocular lensesen
dc.subject.otherRetina -- Surgeryen
dc.subject.otherOphthalmologyen
dc.titleVisual outcome and complications of cataract extraction after pars plana vitrectomyca
dc.typeinfo:eu-repo/semantics/articleca
dc.description.versioninfo:eu-repo/semantics/publishedVersionca
dc.rights.accessLevelinfo:eu-repo/semantics/openAccess
dc.embargo.termscapca
dc.subject.udc61ca
dc.subject.udc617ca
dc.identifier.doihttps://dx.doi.org/10.2147/OPTH.S161223ca


Files in this item

 

This item appears in the following Collection(s)

Show simple item record

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by-nc/3.0/
Share on TwitterShare on LinkedinShare on FacebookShare on TelegramShare on WhatsappPrint